Rankings
▼
Calendar
PRTA Q3 2019 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$512M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$205,000
-19.6% YoY
Gross Profit
-$12M
-5990.7% margin
Operating Income
-$21M
-10230.2% margin
Net Income
-$19M
-9486.8% margin
EPS (Diluted)
$-0.49
QoQ Revenue Growth
+22.8%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$451M
Total Liabilities
$162M
Stockholders' Equity
$289M
Cash & Equivalents
$390M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$205,000
$255,000
-19.6%
Gross Profit
-$12M
-$18M
+32.7%
Operating Income
-$21M
-$24M
+13.8%
Net Income
-$19M
-$25M
+20.8%
← FY 2019
All Quarters
Q4 2019 →